Continued controversy on chrysotile biopersistence

International Journal of Occupational and Environmental Health

Volumn 17, Issue 1, 2011, Pages 99-102

  Egilman, David S ^a  

^a International Journal of Occupational and Environmental Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78751472035     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (28)

1. Donaldson K, Oberdörster G. Continued controversy on chrysotile biopersistence. Int J Occup Environ Health. 2011;17(1):98-99.
2. Vorwald AJ, Durkan TM, Pratt PC. Experimental studies of asbestosis. A M A Arch Ind Hyg Occup Med. Jan 1951; 3(1):1-43.
3. Hardy H, Egilman D. Corruption of occupational medical literature: The asbestos example. Am J Ind Med. 1991;20(1):127-129.
4. Stanton MF, Layard M, Tegeris A, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. Nov 1981;67(5):965-975.
5. Donaldson K, Brown GM, Brown DM, Bolton RE, Davis JM. Inflammation generating potential of long and short fibre amosite asbestos samples. Br J Ind Med. Apr 1989;46(4):271-276.
6. NIOSH. NIOSH criteria for a recommended standard: Occupational Exposure to Asbestos 1972.
7. Lynch JR, Ayer HE, Johnson DL. The interrelationships of selected asbestos exposure indices. Am Ind Hyg Assoc J. Sep-Oct 1970;31(5):598-604.
8. Egilman D. Fiber types, asbestos potency, and environmental causation: A peer review of published work and legal and regulatory scientific testimony. Int J Occup Environ Health. Apr-Jun 2009;15(2):202-228.
9. Finkelstein MM, Dufresne A. Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med. Apr 1999;35(4):401-412.
10. Appel JD, Fasy TM, Kohtz DS, Kohtz JD, Johnson EM. Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA. Proc Natl Acad Sci USA. Oct 1988;85(20):7670-7674.
11. Barrett JC. Cellular and molecular mechanisms of asbestos carcinogenicity: Implications for biopersistence. Environ Health Perspect. Oct 1994;102 Suppl 5:19-23.
12. Walker C, Everitt J, Barrett JC. Possible cellular and molecular mechanisms for asbestos carcinogenicity. Am J Ind Med. 1992;21(2):253-273.
13. Warheit DB, Hartsky MA, Frame SR. Pulmonary effects in rats inhaling sizeseparated chrysotile asbestos fibres or p-aramid fibrils: Differences in cellular proliferative responses. Toxicol Lett. Nov 1996;88(1-3):287-292.
14. Bernstein DM, Hoskins JA. The health effects of chrysotile: Current perspective based upon recent data. Regul Toxicol Pharmacol. Aug 2006;45(3):252-264.
15. Bernstein D, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation: Final results through 1 year after cessation of exposure. Inhal Toxicol. Jan 2005; 17(1):1-14.
16. Miller BG, Searl A, Davis JM, et al. Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg. Apr 1999; 43(3):155-166.
17. Searl A, Buchanan D, Cullen RT, Jones AD, Miller BG, Soutar CA. Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann Occup Hyg. Apr 1999;43(3):143-153.
18. Hesterberg TW, Miller WC, Mast R, McConnell EE, Bernstein DM, Anderson R. Relationship between lung biopersistence and biological effects of man-made vitreous fibers after chronic inhalation in rats. Environ Health Perspect. Oct 1994;102 Suppl 5:133-137.
19. Egilman D, Roberts M. Re: Controlled use of asbestos. Int J Occup Environ Health. Jan-Mar 2004;10(1):99-103.
20. Langer AM, Wolff MS, Rohl AN, Selikoff IJ. Variation of properties of chrysotile asbestos subjected to milling. J Toxicol Environ Health. Jan 1978; 4(1):173-188.
21. Dunnigan J, Nadeau D, Paradis D. Cytotoxic effects of aramid fibres on rat pulmonary macrophages: Comparison with chrysotile asbestos. Toxicol Lett. Mar 1984;20(3):277-282.
22. Jaurand MC, Magne L, Bignon J. The significance of lysosomal enzyme release induced by asbestos. In: Brown RC, Gormley IP, Chamberlain M, Davies RE, eds. The in vitro effects of mineral dusts. London; New York: Academic Press; 1980.
23. Bernstein DM, Chevalier J, Smith P. Comparison of calidria chrysotile asbestos to pure tremolite: Inhalation biopersistence and histopathology following short-term exposure. Inhal Toxicol. Dec 2003;15(14):1387-1419.
24. Ilgren EB. Coalinga fibre: A short-fibre, amphibole-free chrysotile-Part 4: Further evidence for a lack of fibrogenic and tumorigenic activity. Indoor and Built Environment. May-Jun 2002; 11(3):171-177.
25. Pinkerton KE, Brody AR, McLaurin DA, et al. Characterization of three types of chrysotile asbestos after aerosolization. Environ Res. Jun 1983; 31(1):32-53.
26. Roberts F, Mackinnon JL, Cherrie L, Burnett RA, Harper CM. Interobserver variability in analysis of asbestos fibres and asbestos bodies in human lung tissue. Med Sci Law. Apr 2004;44(2): 151-159.
27. Ilgren EB. Concentration and morphology of amphibole minerals present in some sources of chrysotile. 2008 ASTM Johnson Conference; 2008; Burlington, Vermont.
28. Donaldson K. The inhalation toxicology of p-aramid fibrils. Crit Rev Toxicol. 2009;39(6):487-500.